Ebola Treatment Trials Commence in DR Congo

The World Health Organization (WHO) has initiated a significant clinical trial to test potential treatments for the current Ebola outbreak in the Democratic Republic of Congo (DRC). The announcement was made by WHO Director-General Tedros Adhanom Ghebreyesus, who confirmed that the first patient has been enrolled in the study.

This trial is particularly important as there are currently no approved vaccines or treatments specifically for the highly infectious Bundibugyo variant of the virus causing the outbreak. While some patients are recovering without specific therapies, the WHO hopes that effective treatments will significantly increase survival rates.

The collaborative effort is sponsored by the WHO and involves coordination with researchers from the Institut National de Recherche Biomédicale in the DRC, the Institute of Tropical Medicine in Belgium, and the University of Oxford in the UK. This international cooperation underscores the global effort to combat the deadly disease.

The current Ebola outbreak in the DRC, declared a public health emergency by the WHO, has resulted in over 1,400 confirmed cases and more than 438 deaths as of June 30th. The virus, which attacks the body’s immune system and organs, can spread from animals to humans and typically infects individuals through contact with infected animals. Symptoms, including fever, headache, and fatigue, appear suddenly between two to 21 days after exposure.

This development marks a critical step in equipping healthcare professionals with the necessary tools to combat the disease more effectively, potentially saving many more lives in future outbreaks.

Read more at https://nilepost.co.ug/news/353472/ebola-treatments-trial-begins-in-dr-congo